ITP Registry and Accompanying Biospecimen Collection
ConditionImmune Thrombocytopenia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJena University Hospital
About this trial
The objective of this ITP registry is to collect clinical information, including biosampling, from consenting patients with a variety of ITPs at different points in the course of their disease.
Eligibility criteria
Qualifiers
Primary or secondary Immune Thrombocytopenia (ITP)
Age ≥18 years
signed declaration of consent
Disqualifiers
diagnoses that cannot be reconciled with the diagnosis of ITP (esp. heparin-induced thrombocytopenia, pregnancy-associated thrombocytopenia, pseudothrombocytopenia)
no informed consent possible (this covers patients who are unable to understand the nature and scope of participation)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
64Universitätsklinikum Aachen AöR52074, Aachen Germany
Klinikum Altenburger Land GmbH, Klinik für Innere Medizin/Hämatologie/Onkologie04600, Altenburg Germany
MVZ am Klinikum Aschaffenburg63739, Aschaffenburg Germany
MVZ IMD GmbH, IMD Gerinnungszentrum Hochtaunus61352, Bad Homburg Germany
Sponsors and collaborators
Jena University Hospital
Lead sponsor
University Hospital Dresden
Collaborator
Novartis
Collaborator
Swedish Orphan Biovitrum
Collaborator
Grifols Biologicals, LLC
Collaborator
Amgen
Collaborator
argenx
Collaborator
Source ClinicalTrials.gov